| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adaphostin cytoxicity in glioblastoma cells is ROS-dependent and is accompanied by upregulation of heme oxygenase-1
|
Long, Jason
|
|
2006
|
59 |
4 |
p. 527-535
|
article
|
| 2 |
Additive antitumor effect of concurrent treatment of 4-hydroxy tamoxifen with 5-fluorouracil but not with doxorubicin in estrogen receptor-positive breast cancer cells
|
Kurebayashi, Junichi
|
|
2006
|
59 |
4 |
p. 515-525
|
article
|
| 3 |
Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapy
|
Fine, Robert L.
|
|
2006
|
59 |
4 |
p. 429-437
|
article
|
| 4 |
A phase II study of weekly irinotecan as first-line therapy for patients with metastatic pancreatic cancer
|
Ueno, Hideki
|
|
2006
|
59 |
4 |
p. 447-454
|
article
|
| 5 |
A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression
|
Shibata, Stephen
|
|
2006
|
59 |
4 |
p. 549-557
|
article
|
| 6 |
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors
|
Fury, Matthew G.
|
|
2006
|
59 |
4 |
p. 467-475
|
article
|
| 7 |
Clinical evaluation of chemosensitivity testing for patients with unresectable non-small cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST)
|
Kawamura, Masafumi
|
|
2006
|
59 |
4 |
p. 507-513
|
article
|
| 8 |
Effects of mycophenolate mofetil on cisplatin-induced renal dysfunction in rats
|
Saad, Sherif Y.
|
|
2006
|
59 |
4 |
p. 455-460
|
article
|
| 9 |
Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo
|
Lin, Jing
|
|
2006
|
59 |
4 |
p. 439-445
|
article
|
| 10 |
Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia
|
Cao, Xianhua
|
|
2006
|
59 |
4 |
p. 495-505
|
article
|
| 11 |
In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases
|
Shaffer, Scott A.
|
|
2006
|
59 |
4 |
p. 537-548
|
article
|
| 12 |
Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies
|
Holstein, Sarah A.
|
|
2006
|
59 |
4 |
p. 559
|
article
|
| 13 |
Pharmacokinetics of arsenic species in Japanese patients with relapsed or refractory acute promyelocytic leukemia treated with arsenic trioxide
|
Fujisawa, Shinya
|
|
2006
|
59 |
4 |
p. 485-493
|
article
|
| 14 |
Phase I and pharmacologic study of irinotecan and amrubicin in advanced non-small cell lung cancer
|
Yanaihara, Tomoko
|
|
2006
|
59 |
4 |
p. 419-427
|
article
|
| 15 |
Plasma and cerebrospinal fluid pharmacokinetics of pemetrexed after intravenous administration in non-human primates
|
Stapleton, Stacie L.
|
|
2006
|
59 |
4 |
p. 461-466
|
article
|
| 16 |
Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 3. Therapeutic efficacy and safety studies in ovarian cancer xenograft model
|
Devalapally, Harikrishna
|
|
2006
|
59 |
4 |
p. 477-484
|
article
|
Journal description